Phenylpropanoids and polyketides
Medchemexpress LLC Coumarin-3-carboxylic acid | 531-81-7 | MFCD00006852 | 99.9% | 190.15 g/mol | C10H6O4 | 500 G
Coumarin-3-carboxylic acid is an aromatic coumarin derivative (C10H6O4, MW 190.15 g/mol) commonly used as a fluorescence probe for detection of hydroxyl radicals and as a synthetic intermediate in organic and medicinal chemistry. It is supplied in high purity suitable for research and is available in a range of laboratory pack sizes.
- Used as a fluorescence probe for hydroxyl radical detection
- Serves as a synthetic intermediate for coumarin derivatives
- High purity suitable for analytical and research use
- Available in multiple laboratory pack sizes, including bulk options
- Compatible with standard organic solvents for synthesis and analysis
Sigma Aldrich Fine Chemicals Biosciences 7-Methoxycoumarin >=98% | 531-59-9 | MFCD00006876 | 25G
7-Methoxycoumarin >=98% | Purity: >=98% | Mol Wt: 176.17 | 531-59-9 | MFCD00006876 | 25G
Medchemexpress LLC BIIE-0246 hydrochloride | 246146-55-4 | MFCD04113026 | >98.0% | 896.0 g/mol | C49H57N11O6 | 5 MG
BIIE-0246 hydrochloride is a selective, non-peptide antagonist of the neuropeptide Y Y2 receptor supplied as the hydrochloride salt for research use. It is used in pharmacological studies to probe NPY-mediated signaling and is provided at high purity for in vitro and in vivo experiments.
- Selective NPY Y2 receptor antagonist
- High purity (>98.0%) suitable for research
- Hydrochloride salt for improved aqueous solubility
- Molecular formula C49H57N11O6; molar mass 896.0 g/mol
- Available in small research pack sizes, for example 5 MG
Sigma Aldrich Fine Chemicals Biosciences Dihydrocoumarin >=99%, FCC, FG | 119-84-6 | MFCD00006881 | 5KG
Dihydrocoumarin >=99%, FCC, FG | Purity: >=99% | Mol Wt: 148.16 | 119-84-6 | MFCD00006881 | 5KG
Medchemexpress LLC AKT-IN-23 | 1226801-23-5 | 517.52 | 25 MG
AKT-IN-23 is an AKT inhibitor primarily used in cancer research. This compound is known for its specific targeting capabilities.
- Acts as an AKT inhibitor
- Suitable for cancer research applications
- Targets Akt
- Involves the PI3K/Akt/mTOR pathway